Postoperative management of patients undergoing left ventricular assist device implantation;Herzinsuffizienz Intensivmedizinisches Management nach Implantation eines mechanischen Linksherzunterstützungssystems

Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie

Volumn 46, Issue 6, 2011, Pages 424-431

  Rex, Steffen ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HEART ASSIST DEVICE; HEART LEFT VENTRICLE; IMPLANTATION; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; SURGICAL RISK; TREATMENT PLANNING;

ANTICOAGULANTS; ARRHYTHMIAS, CARDIAC; EQUIPMENT FAILURE; HEART FAILURE; HEART VENTRICLES; HEART-ASSIST DEVICES; HEMODYNAMICS; HUMANS; PATIENT SELECTION; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE HEMORRHAGE; PROSTHESIS IMPLANTATION; RESUSCITATION; RISK ASSESSMENT; SURGICAL WOUND INFECTION; THROMBOSIS;

EID: 79959497104     PISSN: 09392661     EISSN: 14391074     Source Type: Journal    
DOI: 10.1055/s-0031-1280747     Document Type: Article

References (33)

1. Wilson SR, Mudge GH Jr., Stewart GC et al. Evaluation for a ventricular assist device: selecting the appropriate candidate. Circulation 2009 119 2225-2232
2. Kirklin JK, Naftel DC, Stevenson LW et al. INTERMACS database for durable devices for circulatory support: first annual report. J Heart Lung Transplant 2008 27 1065-1072
3. Kirklin JK, Naftel DC, Kormos RL et al. Second INTERMACS annual report: more than 1000 primary left ventricular assist device implants. J Heart Lung Transplant 2010 29 1-10
4. Lietz K, Long JW, Kfoury AG et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation 2007 116 497-505 (Pubitemid 47450258)
5. Sidebotham D, McGeorge A, McGuinness S et al. Extracorporeal membrane oxygenation for treating severe cardiac and respiratory failure in adults: part 2 technical considerations. J Cardiothorac Vasc Anesth 2010 24 164-172
6. Sidebotham D, McGeorge A, McGuinness S et al. Extracorporeal membrane oxygenation for treating severe cardiac and respiratory disease in adults: part 1 overview of extracorporeal membrane oxygenation. J Cardiothorac Vasc Anesth 2009 23 886-892
7. Hernandez AF, Grab JD, Gammie JS et al. A decade of short-term outcomes in post cardiac surgery ventricular assist device implantation: data from the Society of Thoracic Surgeons' National Cardiac Database. Circulation 2007 116 606-612 (Pubitemid 47364578)
8. Slaughter MS, Pagani FD, Rogers JG et al. Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant 2010 29 1-39
9. Frazier OH, Myers TJ, Gregoric ID et al. Initial clinical experience with the Jarvik 2000 implantable axial-flow left ventricular assist system. Circulation 2002 105 2855-2860 (Pubitemid 34666098)
10. Slaughter MS, Rogers JG, Milano CA et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009 361 2241-2251
11. Pitsis AA, Visouli AN. Update on ventricular assist device management in the ICU. Curr Opin Crit Care 2008 14 569-578
12. Slaughter MS, Naka Y, John R et al. Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy. J Heart Lung Transplant 2010 29 616-624
13. Schenk S, El-Banayosy A, Prohaska W et al. Heparin-induced thrombocytopenia in patients receiving mechanical circulatory support. J Thorac Cardiovasc Surg 2006 131 1373-1381
14. Schenk S, El-Banayosy A, Morshuis M et al. IgG classification of anti-PF4/heparin antibodies to identify patients with heparin-induced thrombocytopenia during mechanical circulatory support. J Thromb Haemost 2007 5 235-241 (Pubitemid 46139443)
15. Koster A, Huebler S, Potapov E et al. Impact of heparin-induced thrombocytopenia on outcome in patients with ventricular assist device support: single-institution experience in 358 consecutive patients. Ann Thorac Surg 2007 83 72-76 (Pubitemid 44932144)
16. Warkentin TE, Greinacher A, Koster A. Heparin-induced thrombocytopenia in patients with ventricular assist devices: are new prevention strategies required? Ann Thorac Surg 2009 87 1633-1640
17. Matthews JC, Koelling TM, Pagani FD et al. The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates. J Am Coll Cardiol 2008 51 2163-2172 (Pubitemid 351713685)
18. Morgan JA, John R, Lee BJ et al. Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and post-transplant mortality. Ann Thorac Surg 2004 77 859-863 (Pubitemid 38271049)
19. Patel ND, Weiss ES, Schaffer J et al. Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow Heart Mate II devices. Ann Thorac Surg 2008 86 832-840
20. Drakos SG, Janicki L, Horne BD et al. Risk factors predictive of right ventricular failure after left ventricular assist device implantation. Am J Cardiol 2010 105 1030-1035
21. Chumnanvej S, Wood MJ, MacGillivray TE et al. Perioperative echocardiographic examination for ventricular assist device implantation. Anesth Analg 2007 105 583-601 (Pubitemid 47300829)
22. Germann P, Braschi A, Della RG et al. Inhaled nitric oxide therapy in adults: European expert recommendations. Intensive Care Med 2005 31 1029-1041 (Pubitemid 41125333)
23. Winterhalter M, Fischer S, Tessmann R et al. Using inhaled iloprost to wean from cardiopulmonary bypass after implanting a left ventricular assist device. Anesth Analg 2006 103 515-516 (Pubitemid 44140703)
24. Rex S, Missant C, Claus P et al. Effects of inhaled iloprost on right ventricular contractility, right ventriculo-vascular coupling and ventricular interdependence: a randomized placebo-controlled trial in an experimental model of acute pulmonary hypertension. Crit Care 2008 12
25. Rex S, Schaelte G, Metzelder S et al. Inhaled iloprost to control pulmonary artery hypertension in patients undergoing mitral valve surgery: a prospective, randomized-controlled trial. Acta Anaesthesiol Scand 2008 52 65-72
26. Vlahakes GJ, Turley K, Hoffman JI. The pathophysiology of failure in acute right ventricular hypertension: hemodynamic and biochemical correlations. Circulation 1981 63 87-95 (Pubitemid 11213337)
27. Mebazaa A, Pitsis AA, Rudiger A et al. Clinical review: practical recommendations on the management of perioperative heart failure in cardiac surgery. Crit Care 2010 14 201-201
28. Missant C, Rex S, Segers P et al. Levosimendan improves right ventriculovascular coupling in a porcine model of right ventricular dysfunction. Crit Care Med 2007 35 707-715 (Pubitemid 46407782)
29. Santamore WP, Gray L Jr. Significant left ventricular contributions to right ventricular systolic function. Mechanism and clinical implications. Chest 1995 107 1134-1145
30. Jahanyar J, Noon GP, Koerner MM et al. Recurrent device thrombi during mechanical circulatory support with an axial-flow pump is a treatable condition and does not preclude successful long-term support. J Heart Lung Transplant 2007 26 200-203 (Pubitemid 46138083)
31. Chinn R, Dembitsky W, Eaton L et al. Multicenter experience: prevention and management of left ventricular assist device infections. ASAIO J 2005 51 461-470 (Pubitemid 41076784)
32. Rose EA, Gelijns AC, Moskowitz AJ et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001 345 1435-1443
33. Kapur NK, Conte JV, Resar JR. Percutaneous closure of patent foramen ovale for refractory hypoxemia after HeartMate II left ventricular assist device placement. J Invasive Cardiol 2007 19